Vaginal Atrophy

Vaginal atrophy, now commonly discussed as part of genitourinary syndrome of menopause, refers to thinning, dryness, and fragility of vaginal and lower urinary tract tissues related to reduced estrogen. It is most common after menopause, but it may also occur during breastfeeding, after certain cancer treatments, or when ovarian function is suppressed. Pain during intercourse, burning, dryness, urinary frequency, and recurrent urinary tract infections can significantly affect quality of life. ^[1][2][3]

What is vaginal atrophy?

Vaginal atrophy is more than simple dryness. The broader term “genitourinary syndrome of menopause” is preferred because symptoms may involve the vulva, urethra, and bladder in addition to the vagina. Tissue thinning, loss of elasticity, changes in vaginal pH, and reduced natural lubrication all contribute to symptoms. This should not be regarded as an unavoidable part of aging that must simply be tolerated; effective management options exist. ^[1][2][3]

What are the symptoms?

Symptoms can include vaginal dryness, burning, irritation, discomfort or pain during intercourse, reduced lubrication, urinary urgency, burning with urination, and recurrent urinary tract infections. Some patients mainly notice sexual discomfort, while others are more troubled by urinary symptoms or chronic irritation. ^[1][2][3]

Why does it occur?

The main driver is reduced estrogen exposure. Menopause is the most common context, but low-estrogen states such as postpartum lactation, certain endocrine treatments, chemotherapy, radiation, or surgical menopause may also lead to symptoms. The symptoms persist unless the tissue environment improves, which is why simple waiting does not usually solve the problem. ^[1][2][3]

How is the diagnosis made?

Diagnosis is usually clinical and based on symptoms together with examination findings. The goal is also to distinguish vaginal atrophy from infection, dermatoses, and other gynecologic causes of irritation or pain. Not every vaginal burning or dryness complaint is caused by atrophy, so individualized assessment remains important. ^[1][2][3]

What are the treatment options?

Treatment may include vaginal moisturizers, lubricants, and—when appropriate—local vaginal estrogen or other therapies selected according to the patient’s symptoms, risks, and preferences. Some patients improve with nonhormonal measures, while others need local estrogen for adequate relief. Management should be individualized, especially when there is a cancer history or another reason to be cautious with hormonal treatment. ^[1][2][3]

When should you see a doctor?

Medical evaluation is appropriate for ongoing vaginal dryness, burning, pain during intercourse, repeated urinary symptoms, bleeding, or new genital discomfort after menopause. Symptoms should not be normalized to the point that they are left untreated when they are affecting quality of life. ^[1][2][3]

Daily life and long-term follow-up

Daily care may include avoiding irritant products, using suitable lubricants or moisturizers, and maintaining follow-up if symptoms are persistent. Because this is often a chronic tissue state rather than a brief irritation, long-term symptom control and comfort are legitimate treatment goals. ^[1][2]

Why is vaginal atrophy confused with infections?

Because symptoms such as burning, irritation, urinary discomfort, and dyspareunia can overlap with infections or other gynecologic conditions. Repeated self-treatment for “infection” without confirmation may delay the correct diagnosis. ^[1][2][3]

Why is the approach individualized in people with a history of cancer?

Because previous hormone-sensitive cancer or complex medical treatment may influence which therapies are appropriate. These patients often need a more personalized risk-benefit discussion rather than a routine approach. ^[1][2]